Treatment of glioblastoma in Greenlandic patients

Treatment of glioblastoma in Greenlandic patients

ABSTRACTGlioblastoma (GBM), WHO grade IV, is the most common primary malignant brain tumour among adults with a devastating overall survival of 14–22 months. Standard treatment of GBM includes maximum safe resection, radiotherapy plus concomitant and adjuvant temozolomide (TMZ), given over a period...

Full description

Bibliographic Details
Main Authors: Simone Frandsen, Alice Juhl Pedersen, Ole Gredal, Søren Møller, Uka Wilhjelm Geissler, Dorte Schou Nørøxe
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:International Journal of Circumpolar Health
Subjects:
Glioblastoma
Greenland
Inuit
brain cancer
temozolomide
radiotherapy
Online Access:https://www.tandfonline.com/doi/10.1080/22423982.2023.2285077

Internet

https://www.tandfonline.com/doi/10.1080/22423982.2023.2285077

Similar Items